DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ: DMII · FINANCIAL SERVICES · SHELL COMPANIES
$10.02
+0.10% today
Updated 2026-04-30
Market cap
$637.64M
P/E ratio
66.73
P/S ratio
—
EPS (TTM)
$0.15
Dividend yield
—
52W range
$10 – $10
Volume
0.1M
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | $-194299.00 | $-1.02M |
| Capital expenditures | $0.00 | $0.00 |
| Depreciation | — | — |
| Stock-based comp | — | — |
| Free cash flow | $-194299.00 | $-1.02M |
| Investing cash flow | — | — |
| Financing cash flow | — | — |
| Dividends paid | — | — |
| Share repurchases | — | — |
| Debt repayment | — | — |
| Net change in cash | — | — |